Key result
Persistent peridevice leak following LAAO with Amplatzer devices was not significantly associated with worse clinical outcomes compared to no leak (HR 1.62; 95% CI 0.9-2.93; p=0.11).
Why the study?
The natural history of peridevice leak following left atrial appendage occlusion was unknown.
Does persistent peridevice leak following left atrial appendage occlusion with Amplatzer devices increase the risk of ischemic stroke, transient ischemic attack, systemic embolism, or all-cause death?
Observational (n=153)
Blinded analysis
No
Does persistent peridevice leak following left atrial appendage occlusion with Amplatzer devices increase the risk of ischemic stroke, transient ischemic attack, systemic embolism, or all-cause death?
Hazard Ratio: 1.62 (95% CI 0.9–2.93)
p-value: p=0.11
Persistent peridevice leak following LAAO with Amplatzer devices is frequent and stable over 1 year, with a non-significant trend toward worse clinical outcomes.
Should not change LAAO follow-up for persistent PDL; leaves open its thromboembolic impact in larger studies.
Background The natural history of peridevice leak (PDL) following left atrial appendage occlusion (LAAO) is unknown. This study sought to investigate changes of PDL from 2 until 12 months after LAAO, using cardiac computed tomography (CT), and to assess the potential association between persistent PDL and clinical outcomes Methods Single‐center observational study of Amplatzer LAAO implants between 2010 and 2017 (n = 206). Patients with 2 and 12 months cardiac CT were included in the study (n = 153). Images were blindly analyzed. PDL was characterized by frequency and size at the device disc, lobe, and left atrial appendage contrast patency. Patients were followed for the composite outcome of ischemic stroke, transient ischemic attack, systemic embolism, or all‐cause death. Median follow up from LAAO was 3.1 (2.3–4.3) years. Results Contrast patency was present in 101 (66%) and 72 (47%) (p < 0.001) at 2 and 12 months, respectively. PDL was identified at the disc in 103 (67%) patients at 2 months versus 93 (61%) at 12 months (p = 0.08), and at the lobe in 29 (19%) at both time points. PDL area at the disc did not change significantly over time, area: −8.95 mm (95% confidence interval [CI]: −18.9; 1.01) p = 0.08. Permanent atrial fibrillation was independently associated with persistent PDL. Persistent versus no PDL was associated with a 62% worse clinical outcome, however not statistically significant, hazard ratio (HR): 1.62 (95% CI: 0.9–2.93), p = 0.11. Conclusion Persistent PDL was frequently observed following LAAO with Amplatzer devices. The PDL frequency and size appeared unchanged between 2 and 12 months. Persistent PDL was not significantly associated with worse clinical outcomes, yet this needs further delineation in future studies.
No takes yet. Share an insight, caveat, or question.
Korsholm et al. (2022) conducted an observational in Left atrial appendage occlusion (n=153). Persistent peridevice leak vs. No peridevice leak was evaluated on Composite of ischemic stroke, transient ischemic attack, systemic embolism, or all-cause death (HR 1.62, 95% CI 0.9-2.93, p=0.11). Persistent peridevice leak following LAAO with Amplatzer devices was not significantly associated with worse clinical outcomes compared to no leak (HR 1.62; 95% CI 0.9-2.93; p=0.11).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: